FDA Approves First Treatment for Fatty Liver Scarring Disease
Nonalcoholic Fatty Liver Disease may be represented by an increase in one bacteria, in a similar way the microbiome is a biomarker for obesity and end-stage liver fibrosis. Patients suffering from …
